Dietary inulin fibers prevent proton-pump inhibitor (PPI)-induced hypocalcemia in mice

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Hess, Mark W ^a   De Baaij, Jeroen H F ^a   Gommers, Lisanne M M ^a   Hoenderop, Joost G J ^a   Bindels, René J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; FRUCTOSE OLIGOSACCHARIDE; INULIN; MAGNESIUM ION; MESSENGER RNA; OMEPRAZOLE; CALCIUM; FATTY ACID; MAGNESIUM; PROTON PUMP INHIBITOR; S100 CALCIUM BINDING PROTEIN G; S100G PROTEIN, MOUSE;

ABSORPTION; ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALB1 GENE; CALCIOTROPIC GENE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; COLON; CONTROLLED STUDY; DIETARY FIBER; FECES ANALYSIS; GENE; GENE EXPRESSION; HOMEOSTASIS; HYPOCALCEMIA; INFANT; INTESTINE; KIDNEY; LARGE INTESTINE; MAGNESIOTROPIC GENE; MAGNESIUM BLOOD LEVEL; MAGNESIUM HOMEOSTASIS; MALE; MINERAL ABSORPTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTON PUMP INHBITOR INDUCED HYPOCALCEMIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; S100G GENE; SERUM; TRPM6 GENE; TRPV5 GENE; TRPV6 GENE; UPREGULATION; URINE; ADMINISTRATION AND DOSAGE; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; INTESTINE ABSORPTION; METABOLISM; PRECLINICAL STUDY;

ANIMALS; CALCIUM; DIETARY FIBER; DRUG EVALUATION, PRECLINICAL; FATTY ACIDS; HYPOCALCEMIA; INTESTINAL ABSORPTION; INULIN; MAGNESIUM; MALE; MICE, INBRED C57BL; OMEPRAZOLE; PROTON PUMP INHIBITORS; S100 CALCIUM BINDING PROTEIN G;

EID: 84946962339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138881     Document Type: Article

References (43)

1. Metz DC. Managing gastroesophageal reflux disease for the lifetime of the patient: evaluating the longterm options. The American journal of medicine. 2004; 117 Suppl 5A:49S-55S. PMID: 15478853.
2. Sachs G. Proton pump inhibitors and acid-related diseases. Pharmacotherapy. 1997; 17(1):22-37. PMID: 9017763.
3. Tjon JA, Pe M, Soscia J, Mahant S. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy. 2013; 33(9):956-71. doi: 10.1002/phar.1299 PMID: 23712734.
4. Patterson Burdsall D, Flores HC, Krueger J, Garretson S, Gorbien MJ, Iacch A, et al. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. Journal of the American Medical Directors Association. 2013; 14(6):429-32. doi: 10.1016/j.jamda.2013.01.021 PMID: 23583000.
5. Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Alimentary pharmacology & therapeutics. 2012; 36(5):405-13. doi: 10.1111/j.1365-2036.2012.05201.x PMID: 22762246.
6. Florentin M, Elisaf MS. Proton pump inhibitor-induced hypomagnesemia: A new challenge. World journal of nephrology. 2012; 1(6):151-4. doi: 10.5527/wjn.v1.i6.151 PMID: 24175253; PubMed Central PMCID: PMC3782221.
7. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. The New England journal of medicine. 2006; 355(17):1834-6. doi: 10.1056/NEJMc066308 PMID: 17065651.
8. Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R. A case series of proton pump inhibitor-induced hypomagnesemia. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010; 56(1):112-6. doi: 10.1053/j.ajkd.2009.11.019 PMID: 20189276.
9. Mackay JD, Bladon PT. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM: monthly journal of the Association of Physicians. 2010; 103(6):387-95. doi: 10.1093/qjmed/hcq021 PMID: 20378675.
10. Luk CP, Parsons R, Lee YP, Hughes JD. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? The Annals of pharmacotherapy. 2013; 47(6):773-80. doi: 10.1345/aph.1R556 PMID: 23632281.
11. Regolisti G, Cabassi A, Parenti E, Maggiore U, Fiaccadori E. Severe hypomagnesemia during longterm treatment with a proton pump inhibitor. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010; 56(1):168-74. doi: 10.1053/j.ajkd.2010.03.013 PMID:20493607.
12. Negri AL, Valle EE. Hypomagnesaemia/hypokalemia associated with the use of esomeprazole. Current drug safety. 2011; 6(3):204-6. PMID: 22122397.
13. Deroux A, Khouri C, Chabre O, Bouillet L, Casez O. Severe acute neurological symptoms related to proton pump inhibitors induced hypomagnesemia responsible for profound hypoparathyroidism with hypocalcemia. Clinics and research in hepatology and gastroenterology. 2014; 38(5):e103-5. doi: 10.1016/j.clinre.2014.03.005 PMID: 24736034.
14. Leontiadis GI, Moayyedi P. Proton pump inhibitors and risk of bone fractures. Current treatment options in gastroenterology. 2014; 12(4):414-23. doi: 10.1007/s11938-014-0030-y PMID: 25209137.
15. Thongon N, Krishnamra N. Omeprazole decreases magnesium transport across Caco-2 monolayers. World journal of gastroenterology: WJG. 2011; 17(12):1574-83. doi: 10.3748/wjg.v17.i12.1574 PMID: 21472124; PubMed Central PMCID: PMC3070129.
16. Thongon N, Krishnamra N. Apical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers. Experimental & molecular medicine. 2012; 44(11):684-93. doi: 10.3858/emm.2012.44.11.077 PMID: 22940736; PubMed Central PMCID: PMC3509185.
17. Lameris AL, Hess MW, van Kruijsbergen I, Hoenderop JG, Bindels RJ. Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6. Pflugers Archiv: European journal of physiology. 2013; 465(11):1613-20. doi: 10.1007/s00424-013-1306-0 PMID: 23756852.
18. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiological reviews. 2015; 95(1):1-46. doi: 10.1152/physrev.00012.2014 PMID: 25540137.
19. Groenestege WM, Hoenderop JG, van den Heuvel L, Knoers N, Bindels RJ. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. Journal of the American Society of Nephrology: JASN. 2006; 17(4):1035-43. doi: 10.1681/ASN.2005070700 PMID: 16524949.
20. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. The Journal of biological chemistry. 2004; 279(1):19-25. doi: 10.1074/jbc.M311201200 PMID: 14576148.
21. Li M, Du J, Jiang J, Ratzan W, Su LT, Runnels LW, et al. Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7. The Journal of biological chemistry. 2007; 282 (35):25817-30. doi: 10.1074/jbc.M608972200 PMID: 17599911; PubMed Central PMCID: PMC3239414.
22. Topala CN, Groenestege WT, Thebault S, van den Berg D, Nilius B, Hoenderop JG, et al. Molecular determinants of permeation through the cation channel TRPM6. Cell calcium. 2007; 41(6):513-23. doi: 10.1016/j.ceca.2006.10.003 PMID: 17098283.
23. Bai JP, Hausman E, Lionberger R, Zhang X. Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium. Molecular pharmaceutics. 2012; 9 (12):3495-505. doi: 10.1021/mp300323q PMID: 23051182.
24. Petry N, Egli I, Chassard C, Lacroix C, Hurrell R. Inulin modifies the bifidobacteria population, fecal lactate concentration, and fecal pH but does not influence iron absorption in women with low iron status. The American journal of clinical nutrition. 2012; 96(2):325-31. doi: 10.3945/ajcn.112.035717 PMID: 22743314.
25. De Vuyst L, Leroy F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. International journal of food microbiology. 2011; 149(1):73-80. doi: 10.1016/j.ijfoodmicro.2011.03.003 PMID: 21450362.
26. Scharrer E, Lutz T. Effects of short chain fatty acids and K on absorption of Mg and other cations by the colon and caecum. Zeitschrift fur Ernahrungswissenschaft. 1990; 29(3):162-8. PMID: 2251858.
27. Leonhard-Marek S, Gabel G, Martens H. Effects of short chain fatty acids and carbon dioxide on magnesium transport across sheep rumen epithelium. Experimental physiology. 1998; 83(2):155-64. PMID: 9568475.
28. Coudray C, Demigne C, Rayssiguier Y. Effects of dietary fibers on magnesium absorption in animals and humans. The Journal of nutrition. 2003; 133(1):1-4. PMID: 12514257.
29. Coudray C, Feillet-Coudray C, Tressol JC, Gueux E, Thien S, Jaffrelo L, et al. Stimulatory effect of inulin on intestinal absorption of calcium and magnesium in rats is modulated by dietary calcium intakes short- and long-term balance studies. European journal of nutrition. 2005; 44(5):293-302. doi: 10.1007/s00394-004-0526-7 PMID: 15340751.
30. Rondon LJ, Rayssiguier Y, Mazur A. Dietary inulin in mice stimulates Mg2+ absorption and modulates TRPM6 and TRPM7 expression in large intestine and kidney. Magnesium research: official organ of the International Society for the Development of Research on Magnesium. 2008; 21(4):224-31. PMID: 19271420.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. doi: 10.1006/meth.2001.1262 PMID: 11846609.
32. Holloway L, Moynihan S, Abrams SA, Kent K, Hsu AR, Friedlander AL. Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. The British journal of nutrition. 2007; 97(2):365-72. doi: 10.1017/S000711450733674X PMID: 17298707.
33. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995; 108(4):975-82. PMID: 7698613.
34. Coudray C, Tressol JC, Gueux E, Rayssiguier Y. Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats. European journal of nutrition. 2003; 42(2):91-8. doi: 10.1007/s00394-003-0390-x PMID: 12638030.
35. Roberfroid MB. Introducing inulin-type fructans. The British journal of nutrition. 2005; 93 Suppl 1:S13-25. PMID: 15877886.
36. Geeta Shukla AV, Jashandeep Singh and Hariom Yadav. Prebiotic Inulin Alters the Colonic Mass, pH, Microflora and Short Chain Fatty Acids in 1,2-Dimethylhydrazine Dihydrochloride Induced Early Colon Carcinogenesis in Male Laca Mice. J Prob Health. 2014; 2:121. doi: 10.4172/2329-8901.1000121
37. Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S, et al. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Applied and environmental microbiology. 2005; 71(10):6150-8. PMID: 16204533
38. Jung TH, Jeon WM, Han KS. In Vitro Effects of Dietary Inulin on Human Fecal Microbiota and Butyrate Production. Journal of microbiology and biotechnology. 2015. PMID: 26095388.
39. Lutz T, Scharrer E. Effect of short-chain fatty acids on calcium absorption by the rat colon. Experimental physiology. 1991; 76(4):615-8. Epub 1991/07/01. PMID: 1910768.
40. Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. Calcified tissue international. 1993; 53(1):21-5. PMID: 8102318.
41. van de Graaf SF, Hoenderop JG, Bindels RJ. Regulation of TRPV5 and TRPV6 by associated proteins. American journal of physiology Renal physiology. 2006; 290(6):F1295-302. doi: 10.1152/ajprenal.00443.2005 PMID: 16682485.
42. de Baaij JH, Groot Koerkamp MJ, Lavrijsen M, van Zeeland F, Meijer H, Holstege FC, et al. Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal Mg(2+) handling. American journal of physiology Renal physiology. 2013; 305(11):F1563-73. doi: 10.1152/ajprenal.00322.2013 PMID: 24089412.
43. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. Journal of the American Society of Nephrology: JASN. 2007; 18(10):2649-52. doi: 10.1681/ASN.2007070792 PMID: 17804670.